Calpain Inhibitors: Promising Agents in Respiratory Medicine

Abbas       Alshami; Daryelle    S.    Varon; Joseph       Varon

Volume 14, Issue 4, 2018

Page: [187 - 188] Pages: 2

DOI: 10.2174/1573398X1404190126094459

« Previous Next »

Download Options

Rights & Permissions Print Cite

Current Respiratory Medicine Reviews

Title:Calpain Inhibitors: Promising Agents in Respiratory Medicine

Volume: 14 Issue: 4

Author(s): Abbas Alshami, Daryelle S. Varon and Joseph Varon*

Affiliation:

The University of Texas Health Science Center at Houston Clinical Professor of Medicine The University of Texas Medical Branch at Galveston Chief of Critical Care Services, United Memorial Medical Center Houston, Texas 77030,United States

Export Options

Export File:

RIS (for EndNote, Reference Manager, ProCite)

BibTeX

Text

Content:

Citation Only

Citation and Abstract

About this article

Cite this article as:

Alshami Abbas , Varon S. Daryelle and Varon Joseph *, Calpain Inhibitors: Promising Agents in Respiratory Medicine, Current Respiratory Medicine Reviews 2018; 14 (4) . https://dx.doi.org/10.2174/1573398X1404190126094459

DOI https://dx.doi.org/10.2174/1573398X1404190126094459	Print ISSN 1573-398X
Publisher Name Bentham Science Publisher	Online ISSN 1875-6387

About this journal

Call for Papers in Thematic Issues

Submission closes on : 28 April, 2024

Exposure to PM2.5 components is associated with respiratory diseases

Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more

Guest Editor(s): Dr. Mario Sznol